Editorial Type:
Article Category: Research Article
 | 
Online Publication Date: 31 May 2022

Chemotherapy-Induced Peripheral Neuropathy
Level 4—Efficacious

PhD LMFT, LPC
Page Range: 20 – 22
DOI: 10.5298/1081-5937-50.1.03
Save
Download PDF

Chemotherapy-induced peripheral neuropathy (CIPN) can be considered a phantom pain because the sensations of CIPN have no concurrent input into the nervous system. In fact, the damage that is done to the peripheral nerves is, as we know to date, irreversible. There are limited data supporting the use of neuromodulatory techniques to treat CIPN and no trials with aims for prevention. The objective of this article is to review current research on neurofeedback to treat CIPN.

Copyright: © Association for Applied Psychophysiology & Biofeedback

Contributor Notes

Correspondence: Sarah Prinsloo, PhD, LMFT, LPC, email: SPrinsloo@mdanderson.org
  • Download PDF